Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

OFEV is indicated in combination with docetaxel for the treatment of adult patients with locally advanced, metastatic or locally recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after first line chemotherapy.
OFEV is indicated for the treatment of Idiopathic Pulmonary Fibrosis (IPF).
OFEV is indicated for the treatment of chronic fibrosing Interstitial Lung Diseases (ILDs) with a progressive phenotype [see Pharmacology: Pharmacodynamics: Clinical Trials under Actions].
OFEV is indicated to slow the rate of decline in pulmonary function in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD).

Ofev Indications/Uses

nintedanib

Manufacturer:

Boehringer Ingelheim

Distributor:

DKSH